New ANRF Scholars Drive Research Forward to Improve Lives of Rheumatology Patients

With expanded mechanisms and long-term impact, ANRF renews commitment to breakthrough, patient-focused science.

IRVINE, CA – July 10, 2025 – The Arthritis National Research Foundation (ANRF) continues to lead the way in supporting the next generation of scientific talent with the announcement of its 2025–2026 ANRF Scholars. With expanded grant offerings and an unwavering commitment to early-career investigators, ANRF is actively investing in high-impact research that brings us closer to cures and improved care for patients living with arthritis and related autoimmune diseases.

“ANRF is answering the moment by stepping forward,” said Emily Stormoen, CEO of ANRF. “We’re meeting a national need with action, ensuring that innovative research doesn’t stall at the start of a promising career. These scholars represent the best of what’s next in arthritis research and patient care, and we’re honored to be part of their journey.”

Each year, ANRF’s renowned Scientific Advisory Board (SAB) which includes leaders in the field, many of whom were once ANRF grantees, completes a rigorous review process to identify and support the most promising projects in rheumatology and autoimmune disease. These efforts have yielded powerful results: 98% of ANRF scholars remain in research, making meaningful contributions that advance discovery toward real-world therapies for patients.

“Every application is reviewed with care, curiosity, and high scientific standards,” said Craig Walsh, PhD, Chair of the ANRF Scientific Advisory Board. “We fund work that pushes boundaries, and we know firsthand how transformational this support can be. Our scholars go on to shape the field, from foundational discoveries to clinical breakthroughs.”

This year, 20 first and second-year scholars are conducting research in a broad range of diseases, including rheumatoid arthritis, lupus, juvenile idiopathic arthritis, osteoarthritis, psoriatic arthritis, scleroderma, and spondylarthritis. Their work is exploring the deepest mechanisms of autoimmunity, pioneering tools for precision immunology, and illuminating new pathways for prevention, diagnosis, and treatment, research that holds real promise for improving patients’ lives.

ANRF’s 2025–2026 grantmaking is made possible through the generous support of individual donors and institutional partners. Funding was awarded through multiple mechanisms: the Arthritis and Related Autoimmune Disease Research Grant, providing $125,000 per year for two years; Psoriatic Arthritis Research Grants supported by Johnson & Johnson Innovative Medicine and Bristol Myers Squibb, at $125,000; the new Rheum for Kids: Pediatric Joint and Skin Disease Research Grant, offered in collaboration with PeDRA- a powerful partnership that combines the reach and rigor of two national networks; and the new ANRF Postdoctoral Clinical Research Fellowship, a one-year, $50,000 grant aimed at launching outstanding postdoctoral clinicians into independent research careers supported by AbbVie and Johnson & Johnson Innovative Medicine.

We are deeply grateful to our supporters and partners for making this critical investment in arthritis research. Their support funds discovery and shapes the future of care for millions living with autoimmune and inflammatory diseases.

2025–2026 ANRF Scholars

First-Year Scholars

  • Sokratis Apostolidis, MD, University of Pennsylvania
    Research focus: Autoimmune
  • Satomi Arimoto, DDS, PhD, Beth Israel Deaconess Medical Center
    Research focus: Psoriatic arthritis – Bristol Myers Squibb Psoriatic Arthritis Fellow
  • Yuriy Baglaenko, PhD, Cincinnati Children’s Medical Center
    Research focus: Juvenile idiopathic arthritis
  • Samuel Dowling, MD, PhD, Ann & Robert Lurie Children’s Hospital of Chicago
    ANRF Postdoctoral Research Fellowship
    Research focus: Juvenile idiopathic arthritis
  • Megan Hanlon, PhD, Harvard Medical School
    Research focus: Rheumatoid arthritis – Gale “Morrie” Granger Fellowship
  • Nikhil Jiwrajka, MD, University of Pennsylvania
    Research focus: Scleroderma
  • Sivakanthan Kasinathan, MD, PhD, Stanford University
    Research focus: Lupus
  • Alexander Knights, PhD, Washington University in St. Louis
    Research focus: Osteoarthritis
  • Hailyn Nielsen, MD, PhD, University of California, San Francisco
    Research focus: Autoimmune
  • Laura Polivka, MD, PhD, MSc, Cedars-Sinai Medical Center
    Rheum for Kids: Pediatric Joint and Skin Disease Research Grant
    Research focus: Scleroderma
  • Jimin Tan, PhD, New York University School of Medicine
    Research focus: Psoriatic arthritis – Johnson & Johnson Innovative Medicine PsA Fellowship
  • Joy Um, MD, Washington University in St. Louis
    ANRF Postdoctoral Research Fellowship
    Research focus: Spondylarthritis

Second-Year Scholars

  • Robert Corty, MD, PhD, Vanderbilt University Medical Center
    Research focus: Autoimmune – Elizabeth D. Mellins Memorial Fellowship
  • Ayano Kohlgruber, PhD, Boston Children’s Hospital
    Research focus: Rheumatoid arthritis
  • Somanathapura K. NaveenKumar, PhD, University of Michigan Medical School
    Research focus: Lupus
  • Jeremy Tilstra, MD, PhD, University of Pittsburgh
    Research focus: Lupus
  • Chia-Lung Wu, PhD, University of Rochester Medical Center
    Research focus: Osteoarthritis
  • Hongxu Xian, PhD, UC San Diego
    Research focus: Lupus
  • Xinbo Yang, PhD, Memorial Sloan Kettering Cancer Center
    Research focus: Spondylarthritis

Support Our Research

Make a one-time or recurring donation and know you are making a difference by funding cutting-edge arthritis & related autoimmune disease research.

Topics

Recent

60 Minutes to Save Millions

This year, more scientists applied for arthritis and autoimmune disease research funding than at any point in the Arthritis National Research Foundation’s 50-year history. It

Translate »

Connect with ANRF Today!

Stay up -to-date with the latest arthritis news, stories and info.​

Make a Donation

Make a one-time or recurring donation and know that you are making a difference by funding cutting-edge arthritis research.